Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$220.4M
-30.1% from 2023
Prescriptions
796K
$276.75 per claim
Patients
175K
89,531 prescribers
Total spending, 2024
$220.5M
$1,258.44 per patient
Medicare prescription drug plans paid $220.4M for Dexlansoprazole Dr in 2024, for 796,388 prescriptions and refills to 175,133 patients (down 30.1% from 2023). The average cost per claim was $276.75.
California had the highest Medicare cost for Dexlansoprazole Dr in 2024: $32.0M for 130,526 claims, followed by New York ($21.6M).
Henrik Khatchatourian, general practice in Glendale, CA, had the highest Medicare cost for Dexlansoprazole Dr in 2024: 1,381 claims costing $228K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Henrik Khatchatourian Glendale, CA | General Practice | 1,381 | 159 | $228K |
| Sixto R Caro Brooklyn, NY | Internal Medicine | 668 | 166 | $220K |
| Christopher D Bui |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 66,617 | 382,574 | 125,910 | $168.0M |
| 2023 | 89,675 | 799,010 | 178,787 | $315.2M |
| 2024 | 89,531 | 796,388 | 175,133 | $220.4M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 1,096 |
| 200 |
| $217K |
| Victor Lyapis Colusa, CA | General Practice | 1,142 | 141 | $217K |
| Gevork J Maissian Glendale, CA | Internal Medicine | 1,215 | 133 | $206K |
| Garbis Apelian Van Nuys, CA | Family Practice | 1,243 | 158 | $205K |
| 1710074026 | Internal Medicine | 800 | 210 | $197K |
| Vagharshak M Pilossyan Van Nuys, CA | Internal Medicine | 1,093 | 173 | $188K |
| Manvel M Mazmanyan Glendale, CA | General Practice | 921 | 133 | $174K |
| Arutyun Topsakalyan Glendale, CA | General Practice | 957 | 128 | $168K |
| Gary Reznik Los Angeles, CA | Cardiology | 901 | 100 | $162K |
| Homayoun Sharim Beverly Hills, CA | Internal Medicine | 853 | 134 | $161K |
| Herach Yadegarian Glendale, CA | General Practice | 663 | 112 | $160K |
| Xiangsheng Zheng Birmingham, AL | Internal Medicine | 1,006 | 156 | $159K |
| Federico J Gregory-Gonzalez Guaynabo, PR | Gastroenterology | 700 | 154 | $155K |
| Kelvin Mai Santa Ana, CA | Internal Medicine | 532 | 142 | $155K |
| Mark Barats West Hollywood, CA | Nephrology | 859 | 101 | $148K |
| Jaesoo Pak Cerritos, CA | Internal Medicine | 756 | 131 | $148K |
| Eddie C Pyune Garden Grove, CA | Family Practice | 567 | 85 | $144K |
| Jung L Lee Flushing, NY | General Surgery | 728 | 111 | $139K |
| Afshine A Emrani Tarzana, CA | Cardiology | 602 | 107 | $139K |
| Baoen Jiang New York, NY | Internal Medicine | 740 | 142 | $137K |
| Tsovinar Tekkelian Glendale, CA | Internal Medicine | 756 | 102 | $136K |
| Zaven M Arslanian Glendale, CA | General Practice | 532 | 89 | $134K |
| Chun T Wong New York, NY | Gastroenterology | 771 | 167 | $130K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Twi/Upsher | 394,442 | $103.2M |
| Par Pharm. | 288,071 | $89.7M |
| Mylan VTRS | 81,359 | $20.5M |
| TWI Pharmaceuti | 32,852 | $7.1M |